REGN
Regeneron Pharmaceuticals Inc
Price:  
971.19 
USD
Volume:  
420,118.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Regeneron WACC - Weighted Average Cost of Capital

The WACC of Regeneron Pharmaceuticals Inc (REGN) is 8.4%.

The Cost of Equity of Regeneron Pharmaceuticals Inc (REGN) is 8.50%.
The Cost of Debt of Regeneron Pharmaceuticals Inc (REGN) is 4.30%.

Range Selected
Cost of equity 7.40% - 9.60% 8.50%
Tax rate 9.50% - 11.60% 10.55%
Cost of debt 4.00% - 4.60% 4.30%
WACC 7.3% - 9.5% 8.4%
WACC

Regeneron WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.76 0.85
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.40% 9.60%
Tax rate 9.50% 11.60%
Debt/Equity ratio 0.03 0.03
Cost of debt 4.00% 4.60%
After-tax WACC 7.3% 9.5%
Selected WACC 8.4%